Search results
Arbutus, Novavax See Activist Investor Action
Barrons.com· 5 days agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial cash balance and liquidity....
Novavax Awaits FDA Decision on Whether Its Next COVID Shot Can Be Offered in US
US News & World Report· 5 days agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers last month to update their vaccines ...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 6 days agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Nvidia Rocks, Stocks Lost in the Light, Fed Minutes Takeaways, Solomon's Song
TheStreet.com· 6 days agoMarkets appeared to be less than fully prepared that 'various [Fed] participants' had at least...
The growing promise of cancer vaccines
Cosmos· 4 days agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 5 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 6 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 6 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Health Care Up as Vaccine Makers Gain - Health Care Roundup
Market Watch· 7 days agoHealth-care companies rose as reported cases of bird flu in Australia and the U.S. buoyed vaccine makers. Shares of CureVac, BioNTech and Moderna rose by 10%...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WPRI Providence· 5 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly ...